Higher total CD8+ lymphocyte counts were independently associated with longer breast cancer specific survival after multivariate analysis (Hazard Ratio, 0.55; 95% CI, 0.39-0.78; P = 0.001) in a model that included the standard prognostic and predictive factors [6]. This evidence concerns the gene CD8A and breast carcinoma.